PATENT CLAIM ANALYSIS

Application Number: 16381557
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-10
Patent Classification: ["424", "093200"]

Abstract:
The present disclosure provides recombinant nucleic acids comprising one or more polynucleotides encoding a transglutaminase (TGM) polypeptide (e.g., a Transglutaminase-1 (TGM1) polypeptide); viruses comprising the recombinant nucleic acids; compositions comprising the recombinant nucleic acids and/or viruses; methods of their use; and articles of manufacture or kits thereof.

Claim (Index 9):
The pharmaceutical composition of  claim 1 , wherein the TGM polypeptide has at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to the amino acid sequence of SEQ ID NO: 5.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 100.0
- Lexical Diversity: 1.55263
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15393151', '16177153', '15851488', '11166438', '10766897']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7767033331403846
- 35 USC 102 Novelty (BERT): 0.5745763975762065
- Combined Prediction Score: 0.7564906395839668
- Mean Citation Score: 443.620332
- Max Citation Score: 520.2533
- Similarity Product: 339.0818319758415

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test